Adviser Investments LLC Neoleukin Therapeutics, Inc. Transaction History

Adviser Investments LLC

  • $7.95 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 14, 2022
SELL
$0.69 - $1.33 $7,999 - $15,418
-11,593 Reduced 17.73%
53,811 $34,000
Q2 2022

Jul 14, 2022
BUY
$0.92 - $2.25 $17,100 - $41,820
18,587 Added 39.7%
65,404 $67,000
Q1 2022

May 04, 2022
BUY
$1.72 - $5.23 $62,534 - $190,147
36,357 Added 347.58%
46,817 $88,000
Q4 2021

Jan 31, 2022
BUY
$4.65 - $7.75 $48,639 - $81,065
10,460 New
10,460 $50,000

Others Institutions Holding NLTX

# of Institutions
1
Shares Held
199K
Call Options Held
0
Put Options Held
0
View Full List

About Neoleukin Therapeutics, Inc.

NLTX Quotes by TradingView
  • Ticker NLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,579,900
  • Description
  • Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...
More about NLTX
Track This Portfolio

Track Adviser Investments LLC Portfolio

Follow Adviser Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adviser Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adviser Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email